510(k) Report

510(k) · Cleared

Cleared

Aperio GT 450 DX

K232202510(k) TraditionalCleared Apr 16, 2024266-day reviewClass II21 CFR 864.3700

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Leica Biosystems Imaging, Inc. · PSY Whole Slide Imaging System

Cleared on Apr 16, 2024 as substantially equivalent to K190332 (Leica Biosystems Imaging, Inc., 2019) after a 266-day review. Its family tree reaches back 2 generations to 2017. 10 later devices descend from it.

Decided
Apr 16, 2024
Review
266 days
Class
Class II
Product code
PSY
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to DEN160056 (2017). 10 later devices descend from it, 9 citing it directly.

Descendants, by year cleared 2025: 4 descendants cleared2024: 2 descendants cleared2026: 4 descendants clearedDEN160056 · Philips IntelliSite Pathology Solution · Philips Medical Systems Nederland B.V. · 2017K190332 · Aperio AT2 DX System · Leica Biosystems Imaging, Inc. · 2019201620182020202220242026
Descendants, by generation 1 generation forward: 9 descendants2 generations forward: 1 descendant K190332 · Aperio AT2 DX System · Leica Biosystems Imaging, Inc. · 2019DEN160056 · Philips IntelliSite Pathology Solution · Philips Medical Systems Nederland B.V. · 20170
  1. Root · 2 generations backDEN160056 Philips IntelliSite Pathology SolutionPhilips Medical Systems Nederland B.V. · 2017
  2. 1 generation backK190332 Aperio AT2 DX SystemLeica Biosystems Imaging, Inc. · 2019
  3. This deviceK232202 Aperio GT 450 DXLeica Biosystems Imaging, Inc. · 2024
  4. Descendant · cites it directly · 1 of its ownK253554 Aperio GT 450 DX; Aperio GT 180 DXLeica Biosystems Imaging, Inc. · 2026
  5. Descendant · 2 generations on · 0 of its ownK253561 Aperio iQC DX SoftwareLeica Biosystems Imaging, Inc. · 2026
  6. Descendant · cites it directly · 0 of its ownK261380 Concentriq AP-DxProscia, Inc. · 2026
  7. Descendant · cites it directly · 0 of its ownK251952 VirasightVirasoft Corporation · 2026
  8. Descendant · cites it directly · 0 of its ownK252762 HALO AP DxIndica Labs, LLC · 2025

Showing 5 of 10 descendants. See all descendants

Descendants cleared per year

2024: 22025: 42026: 4
2024high 4 (2025) · low 2 (2024)2026

Most influential descendants

Showing 5 of 10 · See all
  • K253554Aperio GT 450 DX; Aperio GT 180 DXLeica Biosystems Imaging, Inc. · 2026 · cites it directly1descendant
  • K253561Aperio iQC DX SoftwareLeica Biosystems Imaging, Inc. · 2026 · 2 generations on0descendants
  • K261380Concentriq AP-DxProscia, Inc. · 2026 · cites it directly0descendants
  • K251952VirasightVirasoft Corporation · 2026 · cites it directly0descendants
  • K252762HALO AP DxIndica Labs, LLC · 2025 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2DEN160056Philips IntelliSite Pathology SolutionPhilips Medical Systems Nederland B.V.2017—
−1K190332Aperio AT2 DX SystemLeica Biosystems Imaging, Inc.2019—
0 (this device)K232202Aperio GT 450 DXLeica Biosystems Imaging, Inc.2024—
+1K253554Aperio GT 450 DX; Aperio GT 180 DXLeica Biosystems Imaging, Inc.2026—
+2K253561Aperio iQC DX SoftwareLeica Biosystems Imaging, Inc.2026—
+1K261380Concentriq AP-DxProscia, Inc.2026—
+1K251952VirasightVirasoft Corporation2026—
+1K252762HALO AP DxIndica Labs, LLC2025—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202420
202540
202640
FIG. 1 — Lineage of K232202, 2017–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PSY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PSY device

  1. #1 K233027 NanoZoomer S360MD Slide scanner systemscore 27.9 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K190332Aperio AT2 DX System
Summary page 6
…Page 1 of 16 Predicate Device Proprietary Name: Aperio AT2 DX System Submission Number: K190332 I. Intended Use The Aperio GT 450 DX is an automated digital slide creation and viewing system. The Aperio GT 450 DX is i…
Leica Biosystems Imaging, Inc.2019—

Also cleared against K190332: 3 other devices →

What descends from it? (10)

9 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K253554Aperio GT 450 DX; Aperio GT 180 DXLeica Biosystems Imaging, Inc.20261
K261380Concentriq AP-DxProscia, Inc.20260
K251952VirasightVirasoft Corporation20260
K252762HALO AP DxIndica Labs, LLC20250
K243391AISight DxPathAI, Inc.20250
K250414CaloPixTribun Health20250
K241273FullFocusPaige.Ai, Inc.20250
K2331198MP Color LCD Displays C811W, C811WT, PA27 and PA27TShenzhen Beacon Display Technology Co., Ltd.20240
K232208Sectra Digital Pathology Module (Version 3.3)Sectra AB20240

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 7 years and passes through 2 companies; a new generation was cleared every 4.9 years on median.
  • None of the 2 ancestors has a recall.
  • Of its descendants, K253554 (Leica Biosystems Imaging, Inc., 2026) has gone furthest, with 1 descendant of its own.
  • 3 other devices also cite its predicate K190332.

How does its category compare?

All PSY devices

PSY Whole Slide Imaging System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · PSY

2in 2025

2017: 22019: 22021: 22022: 12023: 12024: 92025: 22026 (partial year): 4
2007high 9 (2024) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PSY

265in 2024

2024: 265 days median2026 (partial year): 253 days median
2007high 265 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · PSY

1so far in 2026, the most since 2007

2026 (partial year): 1
2007high 1 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · PSY

1in 2023

2019: 12020: 12023: 1
2007high 1 (2019) · low 0 (2007)2025

MAUDE reports naming product code PSY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20172—00
20180—00
20192—01
20200—01
20212—00
20221—00
20231—01
2024926500
20252—00
202642531—

What is it indicated for?

The Aperio GT 450 DX is an automated digital slide creation and viewing system. The Aperio GT 450 DX is intended for in vitro diagnostic use as an aid to the pathologist to review and interpret digital images of surgical pathology slides prepared from formalin-fixed paraffin embedded (FFPE) tissue. The Aperio GT 450 DX is for creation and viewing of digital images of scanned glass slides that would otherwise be appropriate for manual visualization by…

Read the full statement (185 words)

The Aperio GT 450 DX is an automated digital slide creation and viewing system. The Aperio GT 450 DX is intended for

in vitro diagnostic use as an aid to the pathologist to review and interpret digital images of surgical pathology slides

prepared from formalin-fixed paraffin embedded (FFPE) tissue. The Aperio GT 450 DX is for creation and viewing of

digital images of scanned glass slides that would otherwise be appropriate for manual visualization by conventional light

microscopy.

Aperio GT 450 DX is comprised of the Aperio GT 450 DX scanner, which generates images in the Digital Imaging and

Communications in Medicine (DICOM) and in the ScanScope Virtual Slide (SVS) file formats, the Aperio WebViewer

DX viewer, and the displays. The Aperio GT450 DX is intended to be used with the interoperable components specified

in Table 1.

The Aperio GT 450 DX is not intended for use with frozen section, cytology, or non-FFPE hematopathology specimens. It

is the responsibility of a qualified pathologist to employ appropriate procedures and safeguards to assure the validity of

the interpretation of images obtained using the Aperio GT 450 DX.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K232202: Aperio GT 450 DX.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K232202

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026